NUDT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.635800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.150400E-01
Normal-vs-Stage2
8.096800E-01
Normal-vs-Stage3
2.248800E-01
Normal-vs-Stage4
3.068000E-01
Stage1-vs-Stage2
4.756800E-01
Stage1-vs-Stage3
6.210400E-01
Stage1-vs-Stage4
1.300850E-01
Stage2-vs-Stage3
6.009000E-01
Stage2-vs-Stage4
5.879800E-01
Stage3-vs-Stage4
6.444000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.900000E-01
Normal-vs-AfricanAmerican
6.862600E-01
Normal-vs-Asian
4.656000E-01
Caucasian-vs-AfricanAmerican
3.189400E-01
Caucasian-vs-Asian
4.187400E-01
AfricanAmerican-vs-Asian
5.034600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.145400E-01
Normal-vs-Female
7.672000E-01
Male-vs-Female
3.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.085000E-01
Normal-vs-Age(41-60Yrs)
8.571400E-01
Normal-vs-Age(61-80Yrs)
9.114800E-01
Normal-vs-Age(81-100Yrs)
9.773400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.586020E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.129200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.965570E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.143800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.997800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.794200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.945200E-01
Normal-vs-Daily Drinker
1.437020E-01
Normal-vs-Weekly Drinker
7.842600E-01
Normal-vs-Occasional Drinker
8.521800E-01
Normal-vs-Social Drinker
5.295400E-01
Non Drinker-vs-Daily Drinker
1.732560E-01
Non Drinker-vs-Weekly Drinker
4.248000E-01
Non Drinker-vs-Occasional Drinker
2.454800E-01
Non Drinker-vs-Social Drinker
9.394400E-01
Daily Drinker-vs-Weekly Drinker
4.586200E-02
Daily Drinker-vs-Occasional Drinker
1.102010E-02
Daily Drinker-vs-Social Drinker
2.092800E-01
Weekly Drinker-vs-Occasional Drinker
8.193600E-01
Weekly Drinker-vs-Social Drinker
5.208600E-01
Occasional Drinker-vs-Social Drinker
3.338800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.606800E-01
Normal-vs-Grade 2
7.413400E-01
Normal-vs-Grade 3
7.785200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.638200E-01
Grade 1-vs-Grade 3
5.789600E-01
Grade 1-vs-Grade 4
7.606800E-01
Grade 2-vs-Grade 3
4.567000E-01
Grade 2-vs-Grade 4
7.413400E-01
Grade 3-vs-Grade 4
7.785200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.456400E-01
Normal-vs-NonDiabetic
9.593200E-01
Diabetic-vs-NonDiabetic
4.134400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.949800E-01
Normal-vs-NoPancreatitis
9.668800E-01
Pancreatitis-vs-NoPancreatitis
2.319000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.870400E-01
Normal-vs-N1
9.736200E-01
N0-vs-N1
7.798600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.396000E-01
Normal-vs-TP53-NonMutant
3.970600E-01
TP53-Mutant-vs-TP53-NonMutant
9.258400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
